Avastin (Genentech Inc) en es it fr

Avastin (Genentech Inc) Brand names, Avastin (Genentech Inc) Analogs

Avastin (Genentech Inc) Brand Names Mixture

  • No information avaliable

Avastin (Genentech Inc) Chemical_Formula

No information avaliable

Avastin (Genentech Inc) RX_link

http://www.rxlist.com/cgi/generic3/avastin.htm

Avastin (Genentech Inc) fda sheet

Avastin_(Genentech_Inc) FDA

Avastin (Genentech Inc) msds (material safety sheet)

Avastin (Genentech Inc) Synthesis Reference

sequence listed in Presta LG, Chen H, O'Connor SJ, et al Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res, 57: 4593-9, 1997

Avastin (Genentech Inc) Molecular Weight

No information avaliable

Avastin (Genentech Inc) Melting Point

61 oC (FAB fragment), 71 oC (whole mAb) - Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).

Avastin (Genentech Inc) H2O Solubility

No information avaliable

Avastin (Genentech Inc) State

Liquid

Avastin (Genentech Inc) LogP

No information avaliable

Avastin (Genentech Inc) Dosage Forms

Solution (IV Infusion)

Avastin (Genentech Inc) Indication

For treatment of metastatic colorectal cancer

Avastin (Genentech Inc) Pharmacology

Bevacizumab prevents or reduces the formation of blood vessels (angiogenesis) thereby preventing or reducing metatstatic disease progressing. Bevacizumab binds VEGF and prevents vascular endothelial growth and endothelial cell proliferation.

Avastin (Genentech Inc) Absorption

No information avaliable

Avastin (Genentech Inc) side effects and Toxicity

No information avaliable

Avastin (Genentech Inc) Patient Information

No information avaliable

Avastin (Genentech Inc) Organisms Affected

Humans and other mammals